Nomura
http://www.nomura.com/Nomura (NYSE: NMR) is a global investment banking and securities firm. The firm’s operations include Domestic Retail, Global Markets, Global Investment Banking, Global Merchant Banking, and Asset Management. Nomura is headquartered in Tokyo, Japan.
Nomura is represented in the Americas by Nomura Holding America (NHA). NHA’s major divisions are Fixed Income, Investment Banking, Equities and Asset Management.
View Older Stories View More Recent Stories
-
Nomura Securities Starts Goldman Sachs (GS) at Neutral
-
Nomura Securities Starts Stifel Financial (SF) at Neutral
-
Nomura Securities Starts Lazard (LAZ) at Neutral
-
Nomura Securities Starts TD Ameritrade (AMTD) at Neutral
-
Nomura Securities Starts JPMorgan (JPM) at Neutral, $61 PT
-
Nomura Securities Starts Morgan Stanley (MS) at Neutral, $34 PT
-
Nomura Securities Starts Evercore Partners (EVR) at Buy, $72 PT
-
Nomura Securities Starts Raymond James (RJF) at Buy, $60 PT
-
Nomura Securities Starts E*TRADE (ETFC) at Buy, $23 PT
-
Nomura Securities Starts LPL Investment (LPLA) at Buy
-
Nomura Securities Starts Bank of America (BAC) at Buy, $19 PT
-
Nomura Securities Starts Citigroup (C) at Buy, $70 PT
-
Notable Analyst Rating Changes 01/08: (RAD) (PNRA) (FLIR) Upgraded; (AMBA) (TWTR) (TCS) Downgraded
-
Mullaly News 'Disappointing' for Microsoft (MSFT): Rick Sherlund
-
Nomura Securities Starts Infinity Pharmaceutical (INFI) at Neutral
-
Nomura Securities Starts Amgen (AMGN) at Neutral, $131 PT
-
Nomura Securities Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral, $75 PT
-
Nomura Securities Starts Synageva BioPharma (GEVA) at Buy, $85 PT
-
Nomura Securities Starts Incyte (INCY) at Buy, $68 PT
-
Nomura Securities Starts Pharmacyclics (PCYC) at Buy
-
Nomura Securities Starts Alexion Pharmaceuticals (ALXN) at Buy, $150 PT
-
Nomura Securities Starts Biogen (BIIB) at Buy, $368 PT
-
Nomura Securities Starts Celgene (CELG) at Buy
-
Nomura Securities Starts Neurocrine Bio. (NBIX) at Buy
-
Nomura Securities Starts Gilead Sciences (GILD) at Buy; Top Biotech Stock Pick for 2014
-
Notable 52-Week Highs and Lows of the Day 01/07: (PLUG) (NBIX) (MGM) High; (COCO) (UNXL) Low
-
Wynn (WYNN), MGM (MGM), Las Vegas Sands (LVS) Estimates and Price Targets Raised at Nomura
-
FireEye (FEYE) Target Ratcheted Higher at Nomura Following Mandiant Deal
-
UPDATE: Pershing Square Maintains 26.2% Exposure to Howard Hughes (HHC), Extends Swaps
-
Nomura's Sherlund Positive on FireEye's (FEYE) Mandiant Acqusition
-
Fannie (FNMA), Freddie (FMCC) Recovered $7.9B from PLS Settlements in 2013
-
Norwegian Cruise Line Announces Exercise of Underwriters' Option to Purchase Additional Shares
-
Larger Price Hike Expected from DirecTV (DTV) in FY14; Will Aim to Offset Content Costs - Analyst
-
Gates Global Files $100M IPO
-
Streetinsider.com's Hot Lunchtime Reads 12/20: (AMBA) (TSLA) (DIS) (MKTO)
-
Coca-Cola Enterprises (CCE) Target Bumped Up at Nomura; 'Neutral' Maintained
-
Sherlund Says It's Less Likely Alan Mulally Get Tapped for Microsoft (MSFT) CEO Spot
-
Nomura Securities Downgrades Global Payments (GPN) to Neutral
-
Nomura Securities Upgrades Total System Services (TSS) to Buy
-
Tapering Eve: Part II
-
Avago (AVGO) Target Lifted to $60 at Nomura on LSI Deal
-
Pre-Open Stock Movers 12/16: (PATH) (LSI) (AER) Higher; (PIP) (CRUS) (TWTR) Lower (more...)
-
Nomura Securities Downgrades Arcelor Mittal (MT) to Reduce
-
Marriott International (MAR) PT Raised to $57 at Nomura
-
Nomura Securities Upgrades Starwood Hotels & Resorts (HOT) to Buy
-
Nomura Securities Upgrades Host Hotels (HST) to Buy
-
Nomura Securities Upgrades Hyatt Hotels (H) to Buy
-
Nomura Securities Starts Pentair (PNR) at Buy
-
Fidelity & Guaranty Life (FGL) IPO Opens Higher
-
F5 Networks (FFIV) Momentum in Security Confirmed by Survey - Nomura

